TAROPHEN 18 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

şimdi satın al

Aktif bileşen:

METHYLPHENIDATE HYDROCHLORIDE

Mevcut itibaren:

TARO INTERNATIONAL LTD, ISRAEL

ATC kodu:

N06BA04

Farmasötik formu:

TABLETS EXTENDED RELEASE

Kompozisyon:

METHYLPHENIDATE HYDROCHLORIDE 18 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

SUN PHARMACEUTICAL INDUSTRIES, INC,USA

Terapötik alanı:

METHYLPHENIDATE

Terapötik endikasyonlar:

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Yetkilendirme tarihi:

2023-05-08

Bilgilendirme broşürü

                                Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) – 1986
This medicine is dispensed with a doctor’s prescription only
Tarophen 18 mg
Tarophen 27 mg
Tarophen 36 mg
Tarophen 54 mg
Extended-release tablets
Active ingredient
Each Tarophen 18 mg tablet contains 18 mg methylphenidate
hydrochloride.
Each Tarophen 27 mg tablet contains 27 mg methylphenidate
hydrochloride.
Each Tarophen 36 mg tablet contains 36 mg methylphenidate
hydrochloride.
Each Tarophen 54 mg tablet contains 54 mg methylphenidate
hydrochloride.
Inactive ingredients and allergens in this medicine: see section 6
‘Additional
information’.
Read the entire leaflet carefully before you start using this
medicine.
This leaflet contains concise information about this medicine. If you
have any
further questions, consult your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar to
yours.
1. What is this medicine intended for?
Tarophen is intended for the treatment of Attention Deficit
Hyperactivity
Disorder (ADHD) in children over the age of 6, adolescents, and adults
up to
the age of 65.
Therapeutic group: central nervous system stimulant.
Tarophen can improve attention and concentration, and reduce
impulsiveness
and hyperactivity in individuals with ADHD. Tarophen should be given
as part
of an ADHD treatment program that may include counseling or other
therapies.
2. Before using this medicine
Do not use this medicine if you or your child:
•
is sensitive (allergic) to the active ingredient (methylphenidate
hydrochloride) or to any of the other ingredients in this medicine
(see
section 6, ‘Additional information’).
•
is very anxious, mentally tense, or agitated (suffers from
restlessness)
•
has an eye problem called glaucoma (increased intraocular pressure)
•
has tics or Tourette's syndrome, or a family history of Tourette's
syndrome. Tics are involuntary repeated movements or sounds.
•
is 
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü Arapça 08-08-2023
Bilgilendirme broşürü Bilgilendirme broşürü İbranice 08-08-2023

Bu ürünle ilgili arama uyarıları

Belge geçmişini görüntüleyin